Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Luckily for you, our job at StockStory is to help you avoid short-term fads by pointing you toward high-quality businesses that can generate sustainable long-term growth. That said, here are three growth stocks climbing an uphill battle and some other opportunities you should consider instead.
Supernus Pharmaceuticals (SUPN)
One-Year Revenue Growth: +20.4%
With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals (NASDAQ: SUPN) develops and markets treatments for central nervous system disorders including epilepsy, ADHD, Parkinson's disease, and migraine.
Why Are We Wary of SUPN?
- Annual revenue growth of 5.9% over the last five years was below our standards for the healthcare sector
- Revenue base of $776.9 million puts it at a disadvantage compared to larger competitors exhibiting economies of scale
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
Supernus Pharmaceuticals is trading at $51.18 per share, or 3.3x forward price-to-sales. To fully understand why you should be careful with SUPN, check out our full research report (it’s free).
Reinsurance Group of America (RGA)
One-Year Revenue Growth: +17.1%
Operating behind the scenes of the insurance industry since 1973, Reinsurance Group of America (NYSE: RGA) provides life and health reinsurance services to insurance companies, helping them manage risk and meet regulatory requirements.
Why Are We Cautious About RGA?
- Outsized scale creates growth headwinds as its 2.1% annualized net premiums earned increases over the last two years underperformed other financial institutions
- Incremental sales over the last two years were less profitable as its 7.8% annual earnings per share growth lagged its revenue gains
- Book value per share is projected to decrease by 3.9% over the next 12 months as capital generation weakens
Reinsurance Group of America’s stock price of $210.55 implies a valuation ratio of 1x forward P/B. Dive into our free research report to see why there are better opportunities than RGA.
Black Stone Minerals (BSM)
One-Year Revenue Growth: +21.3%
With roots dating to the late 1800s when railroads were expanding westward and land grants were common, Black Stone Minerals (NYSE: BSM) owns oil and natural gas mineral rights across the U.S., earning royalties when energy companies drill on its land.
Why Is BSM Not Exciting?
- Subscale operations are evident in its revenue base of $470 million, meaning it has fewer distribution channels than its larger rivals
- Efficiency has decreased over the last five years as its EBITDA margin fell by 28.1 percentage points
At $13.84 per share, Black Stone Minerals trades at 13x forward P/E. Read our free research report to see why you should think twice about including BSM in your portfolio.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
